Epilepsy Surgery Indications
What Do You Need to Know?
- Drug-resistant epilepsy = failure of 2 appropriate ASMs at adequate doses (ILAE definition); refer early — do NOT wait for 5+ ASM failures
- Best surgical candidates: focal onset seizures with an identifiable MRI lesion and concordant presurgical data
- ERSET trial: early surgery for mTLE = 73% seizure-free vs. 0% with continued medical therapy — surgery is superior, not a last resort
- Temporal lobectomy is the most common and most successful epilepsy surgery; 60–80% Engel I for MTLE with hippocampal sclerosis
- Presurgical workup: Phase I (video-EEG, MRI epilepsy protocol, PET, neuropsych) → Phase II (SEEG or grids) if non-concordant
- Palliative options: corpus callosotomy for drop attacks (LGS); hemispherotomy for hemispheric epilepsy syndromes (Rasmussen, Sturge-Weber)
- Engel classification: Class I = seizure-free (Ia = completely free, Ib = auras only); the standard outcome measure for epilepsy surgery
Surgical Candidacy — When to Refer
Drug-Resistant Epilepsy (ILAE Definition)
- Definition: failure to achieve sustained seizure freedom after adequate trials of 2 tolerated, appropriately chosen ASMs (monotherapy or combination)
- After 2 ASM failures, probability of seizure freedom with each additional agent drops to ~5%
- Refer to a comprehensive epilepsy center as soon as drug resistance is established
- Average delay from drug resistance to surgery referral is 10–20 years — this is unacceptable given Level 1 evidence
Landmark Trials Supporting Early Surgery
| Trial |
Year |
Design |
Key Result |
| Wiebe et al. |
2001 (NEJM) |
RCT: ATL vs. medical therapy for TLE |
58% vs. 8% seizure-free at 1 year; NNT = 1.6 |
| ERSET |
2012 (JAMA) |
RCT: early surgery vs. continued medical therapy |
73% vs. 0% seizure-free at 2 years |
- NNT of 1.6 (Wiebe) is among the largest treatment effects in clinical neurology
- Earlier surgery → better cognitive outcomes, better psychosocial functioning, lower SUDEP risk
Ideal Candidates
- Focal onset seizures with an identifiable epileptogenic focus
- MRI-visible lesion (hippocampal sclerosis, FCD, low-grade tumor, cavernoma)
- Concordance across all presurgical modalities (EEG, MRI, PET, semiology, neuropsych)
- mTLE with hippocampal sclerosis = the “ideal” surgical candidate
Relative & Absolute Contraindications
| Contraindication |
Type |
Notes |
| Primary generalized epilepsy |
Absolute (for resective surgery) |
May still be considered for palliative procedures (callosotomy, VNS) |
| Progressive/degenerative cause |
Absolute |
Neurodegenerative or metabolic etiologies with diffuse involvement |
| Bilateral independent foci |
Relative |
May proceed if one focus is clearly dominant or if palliative surgery is planned |
| Focus in eloquent cortex |
Relative |
Cortical mapping (SEEG, fMRI) needed; consider neuromodulation (RNS) as alternative |
| Severe psychiatric comorbidity |
Relative |
Active psychosis or suicidality may need stabilization first; not absolute |
Board Pearls
- Drug-resistant epilepsy = failure of 2 ASMs (not 3, not 5) — boards test this ILAE threshold repeatedly
- After 2 ASM failures, each additional agent adds only ~5% chance of seizure freedom — surgery should be discussed, not deferred
- Primary generalized epilepsy is NOT a candidate for resective surgery but may benefit from callosotomy or neuromodulation
Presurgical Evaluation — The Neurology Perspective
Phase I (Noninvasive)
| Modality |
What It Shows |
Key Points |
| Video-EEG monitoring |
Seizure-onset zone, semiology, interictal discharges |
Gold standard; capture ≥3–5 habitual seizures; typically 5–14 day admission |
| 3T MRI (epilepsy protocol) |
Structural lesion (HS, FCD, tumors, cavernomas) |
NOT a “routine brain MRI”; includes 3D T1/FLAIR, coronal T2 perpendicular to hippocampus, SWI |
| FDG-PET |
Interictal hypometabolism at epileptogenic zone |
80–90% sensitivity for mTLE; more sensitive than MRI for subtle lesions |
| Ictal SPECT (SISCOM) |
Ictal hyperperfusion at seizure-onset zone |
Must inject within 30 sec of seizure onset; >45 sec = propagation, not onset |
| MEG / MSI |
Magnetic source imaging of interictal discharges |
Most useful in MRI-negative cases; detects sulcal cortex better than EEG |
| Neuropsychological testing |
Baseline cognition; lateralization of language/memory |
Verbal memory deficit → left temporal; visuospatial → right temporal |
Phase II (Invasive Monitoring)
- Indications: non-concordant Phase I data, MRI-negative cases, seizure onset near eloquent cortex, bilateral independent onsets
- Required in 30–40% of surgical candidates
SEEG vs. Subdural Grids
| Feature |
SEEG (Stereo-EEG) |
Subdural Grids |
| Implantation |
Stereotactic via twist-drill holes; robot-assisted |
Open craniotomy |
| Spatial coverage |
Deep structures (hippocampus, insula, cingulate); bilateral feasible |
Cortical surface; limited deep access |
| Complications |
Hemorrhage 1–4%; infection 1–2% |
Overall 10–15% (hemorrhage, infection, edema) |
| Cortical mapping |
Limited by electrode geometry |
Excellent for motor/language mapping |
| Current trend |
Has largely replaced grids in North America |
Declining; reserved for specific cortical mapping needs |
Language & Memory Lateralization
- fMRI: has replaced the Wada test for language lateralization (>90% concordance); noninvasive, widely available
- Wada test (intracarotid amobarbital): still needed for memory lateralization, especially before dominant temporal resection
- Left hemisphere = language dominant in 95% of right-handers, ~70% of left-handers
The Concordance Principle
- All modalities must point to the same focus — this is the fundamental principle of presurgical evaluation
- Full concordance (semiology + EEG + MRI + PET + neuropsych) → >70% seizure-free outcome
- Discordance → need Phase II investigation or may not be a surgical candidate
- Final decision made at multidisciplinary epilepsy surgery conference
Board Pearls
- FDG-PET = interictal HYPOmetabolism; Ictal SPECT = ictal HYPERperfusion — opposite findings, both localizing the epileptogenic zone
- fMRI replaces Wada for language; Wada still needed for memory lateralization (especially left TLE)
- SEEG has replaced subdural grids at most centers: lower complications, better deep structure access, bilateral sampling
Temporal Lobectomy
Overview
- Most common and most successful epilepsy surgery worldwide
- Standard procedure for mesial temporal lobe epilepsy (mTLE) with hippocampal sclerosis
- Engel I outcome: 60–80% for mTLE-HS at 1 year; 40–55% without HS
Anterior Temporal Lobectomy (ATL)
- Standard open approach: resects anterior temporal neocortex + mesial structures (amygdala, hippocampus, parahippocampal gyrus)
- Resection extent — dominant hemisphere: 3.5–4.5 cm from temporal pole
- Resection extent — nondominant hemisphere: 5–6 cm from temporal pole
- Highest seizure-free rates among all surgical approaches for mTLE
Selective Amygdalohippocampectomy (SAH)
- Targets only mesial structures while preserving lateral temporal neocortex
- Engel I: 55–65% — slightly lower than standard ATL
- Better cognitive preservation: naming and verbal memory decline less than ATL
- Preferred when cognitive preservation is a priority, especially dominant hemisphere
Complications of Temporal Resection
| Complication |
Incidence |
Mechanism |
| Superior quadrantanopia |
~18% |
Disruption of Meyer loop (optic radiation in temporal lobe) |
| Verbal memory decline |
Up to 44% (left ATL) |
Dominant mesial temporal resection; worse with strong preop memory |
| Naming difficulty |
34% (dominant side) |
Lateral temporal neocortex resection |
| De novo psychiatric symptoms |
10–20% |
Depression, anxiety; “burden of normality” |
| Major permanent deficit |
4.7% |
Hemiparesis, hemianopia |
| Mortality |
<0.6% |
All epilepsy surgeries combined |
Board Pearls
- Superior quadrantanopia (“pie in the sky”) = classic visual field cut from temporal lobectomy due to Meyer loop disruption
- Left ATL carries highest cognitive risk: verbal memory decline up to 44%, naming decline 34%
- Dominant ATL resection limit = 3.5–4.5 cm; nondominant = 5–6 cm from temporal pole — boards test this
Lesionectomy
Principle
- Resection of a discrete epileptogenic lesion + surrounding epileptogenic zone
- Complete resection = the single strongest predictor of seizure freedom regardless of pathology
Outcomes by Pathology
| Pathology |
Engel I Rate |
Key Considerations |
| Low-grade tumors (ganglioglioma, DNET) |
75–90% |
Best outcomes; gross total resection is critical |
| Cavernous malformations |
70–80% |
Resect surrounding hemosiderin ring; ECoG-guided resection improves outcomes |
| FCD Type IIb |
70–80% |
Best outcomes among FCD subtypes; transmantle sign on MRI; FCD II overall 50–70% |
| Hippocampal sclerosis |
60–70% |
Standard ATL or SAH; concordant data critical |
| MRI-negative |
30–45% |
Least favorable; requires Phase II (SEEG); advanced MRI postprocessing may reveal subtle FCD |
FCD Type II — Why Outcomes Are Excellent
- Well-defined margins (especially IIb with balloon cells)
- Transmantle sign on MRI aids complete resection
- FCD IIb > FCD IIa > FCD I for seizure-free outcomes
- Incomplete resection is the primary cause of surgical failure
Clinical Pearl
When evaluating a patient with a brain lesion and epilepsy, remember that the epileptogenic zone may extend beyond the visible lesion. ECoG (intraoperative electrocorticography) can guide resection margins. Complete resection of both the lesion and the surrounding epileptogenic cortex → best outcomes.
Corpus Callosotomy
Indications
- Primary indication: disabling drop attacks (tonic, atonic seizures) refractory to medical therapy
- Lennox-Gastaut syndrome (LGS) is the most common indication
- Palliative procedure — does NOT cure epilepsy; reduces frequency/severity of the most disabling seizure type
- Not for focal resectable epilepsy; reserved for generalized or multifocal epilepsy
Surgical Approach
- Staged approach preferred: anterior 2/3 callosotomy first
- If drop attacks persist → complete callosotomy (higher efficacy but higher morbidity)
- Anterior 2/3 disrupts the primary pathways for bilateral seizure propagation causing drop attacks
Outcomes
- Eliminates drop attacks: ~55% of patients
- Complete seizure freedom: only 19%
- Better outcomes with: infantile spasms history, shorter epilepsy duration, complete callosotomy
Disconnection Syndrome
- Alien hand syndrome: hand acts independently of will; more common with complete callosotomy
- Split-brain effects: interhemispheric transfer deficits — cannot name objects placed in left hand, bimanual coordination problems
- Transient postop deficits: leg weakness, akinesia, mutism (medial frontal retraction) — usually resolve in days to weeks
- Risk significantly higher with complete callosotomy → supports staged approach
Board Pearls
- Corpus callosotomy = the board answer for disabling drop attacks in LGS
- Staged approach: anterior 2/3 first, then complete if needed
- Alien hand syndrome = classic board complication of complete callosotomy
- It is a palliative procedure — does NOT make patients seizure-free
Hemispheric Surgery
Indications
| Condition |
Key Features |
Notes |
| Rasmussen encephalitis |
Progressive unilateral encephalitis; epilepsia partialis continua |
Hemispherotomy is the definitive treatment; immunotherapy does not cure |
| Sturge-Weber syndrome |
Hemispheric leptomeningeal angiomatosis |
Consider early surgery for refractory seizures |
| Hemimegalencephaly |
Unilateral hemispheric enlargement with cortical malformation |
Early surgery; often presents in infancy |
| Large hemispheric FCD |
Extensive unilateral cortical dysplasia |
When the entire hemisphere is involved or multiple lobes affected |
| Perinatal stroke |
Large unilateral infarction with resultant epilepsy |
Preexisting hemiparesis; good plasticity potential |
Hemispherectomy vs. Hemispherotomy
- Anatomic hemispherectomy: complete hemisphere removal — historical; associated with late complications (superficial hemosiderosis, hydrocephalus)
- Functional hemispherotomy: preferred modern technique — disconnects hemisphere while preserving most cortex in situ
- Techniques: vertical parasagittal, periinsular, endoscopic-assisted
- Hemispherotomy has equivalent seizure outcomes with less morbidity than anatomic hemispherectomy
Outcomes
- 73% seizure-free in children at last follow-up
- Best outcomes in younger children (greater neuroplasticity for functional reorganization)
- Most candidates already have preexisting contralateral hemiparesis and hemianopia
Expected Deficits
- Contralateral hemiparesis: most already have preoperative hemiparesis; upper extremity typically more affected
- Homonymous hemianopia: expected and accepted
- Language: children with early-onset hemispheric pathology have significant language reorganization to the contralateral hemisphere
- Complications: hydrocephalus requiring shunt (10–20%), hemorrhage, aseptic meningitis
Board Pearls
- Rasmussen encephalitis → hemispherotomy = the definitive treatment; do not delay for immunotherapy
- Functional hemispherotomy is preferred over anatomic hemispherectomy (equivalent seizure outcomes, less morbidity)
- 73% seizure-free in children; best outcomes in younger patients due to neuroplasticity
Engel Outcome Classification
| Engel Class |
Outcome |
Subclasses |
| Class I |
Free of disabling seizures |
Ia = completely seizure-free; Ib = auras only; Ic = some seizures postop but seizure-free ≥2 years; Id = generalized seizures only with ASM withdrawal |
| Class II |
Rare disabling seizures |
Almost seizure-free; rare seizures after initial complete control |
| Class III |
Worthwhile improvement |
Meaningful seizure reduction but ongoing disabling seizures |
| Class IV |
No worthwhile improvement |
No significant change or worsening of seizures |
Board Pearls
- Engel Ia = completely seizure-free (the goal of surgery)
- Engel Ib = auras only — still classified as “free of disabling seizures”; boards may present a patient with only auras and ask you to classify — this is Class Ib, NOT Class II
- Engel classification is the standard outcome measure for epilepsy surgery across all clinical trials
Surgery Types by Indication — Summary
| Surgery Type |
Primary Indication |
Engel I Rate |
Key Notes |
| ATL |
mTLE with hippocampal sclerosis |
60–70% |
Most common epilepsy surgery; Level 1 RCT evidence |
| SAH |
mTLE (cognitive preservation priority) |
55–65% |
Preserves lateral temporal neocortex; better naming |
| Lesionectomy |
FCD, cavernomas, low-grade tumors |
50–90% |
Outcomes depend on pathology and completeness of resection |
| Corpus callosotomy |
Drop attacks in LGS |
19% (55% drop-free) |
Palliative; staged anterior 2/3 first |
| Hemispherotomy |
Rasmussen, Sturge-Weber, hemimegalencephaly |
73% (children) |
Functional disconnection preferred over anatomic removal |
| LITT / SLAH |
mTLE (minimally invasive alternative) |
55–60% |
MRI-guided laser ablation; 1–2 day hospital stay |
Clinical Pearl
When discussing epilepsy surgery with patients, present the trade-off between seizure-free rates and invasiveness: ATL has the highest seizure-free rates for mTLE but greatest cognitive risk; SAH and LITT offer better cognitive preservation at modestly lower seizure-free rates. LITT does not “burn bridges” — open ATL remains fully feasible after failed LITT.
Temporal Lobectomy Outcomes — Comparison Table
| Feature |
ATL |
SAH |
LITT/SLAH |
| Engel I at 1 year |
60–70% |
55–65% |
55–60% |
| Approach |
Open craniotomy |
Open craniotomy |
3.2 mm burr hole (MRI-guided) |
| Hospital stay |
3–5 days |
3–5 days |
1–2 days |
| Naming decline (dominant) |
34% |
Lower than ATL |
Lowest risk |
| Verbal memory decline (left) |
Up to 44% |
Better than ATL |
Best preservation |
| Visual field defect |
~18% |
Variable by approach |
8.8% |
| Recovery time |
4–6 weeks |
4–6 weeks |
1–2 weeks |
| Salvage after failure |
Limited |
ATL possible |
ATL fully feasible |
Board Pearls
- Drug-resistant epilepsy = failure of 2 ASMs — refer for surgery evaluation immediately; do NOT wait years
- Temporal lobectomy for mTLE-HS: 60–80% Engel I; NNT = 1.6 (Wiebe 2001); ERSET = 73% vs. 0%
- Superior quadrantanopia = Meyer loop disruption = classic visual field cut of temporal lobectomy
- Left ATL: verbal memory decline up to 44%, naming decline 34% — highest cognitive risk
- Lesionectomy outcome hierarchy: ganglioglioma/DNET (75–90%) > cavernoma (70–80%) > FCD IIb (70–80%) > HS (60–70%) > MRI-negative (30–45%)
- Corpus callosotomy = drop attacks in LGS; staged anterior 2/3 first; alien hand syndrome = classic complication of complete callosotomy
- Rasmussen encephalitis → hemispherotomy is the definitive treatment; functional hemispherotomy preferred over anatomic hemispherectomy
- Engel Ib = auras only = still “free of disabling seizures”; do NOT classify as Class II
Clinical Pearl
Cross-reference: Detailed epilepsy surgery content including ATL, SAH, LITT, lesionectomy, callosotomy, hemispherotomy, long-term outcomes, and ASM management post-surgery is covered in depth in the Epilepsy specialty section (Epilepsy Surgery and Presurgical Evaluation topics). This note focuses on surgical indications from the neurosurgical referral perspective.